Page 13 - Demo

Jadkar, et al.: Management of ovarian adenocarcinoma in an IVF pregnancy6 MOGS Chronicles | Volume 1 | Issue 1 | September 2024%u00a9 The Author(s). 2024 Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons. org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/ zero/1.0/) applies to the data made available in this article, unless otherwise stated.Editor%u2019s NoteThis case report presents a rare instance of EOC diagnosed during pregnancy, highlighting the complexities of management for a good maternal and fetal outcome. It also necessitates the need for awareness of this condition. Ultrasound is an optimum diagnostic tool, but it cannot differentiate between benign and low malignant potential tumours, therefore, MRI is required for further evaluation. It is safe to perform in 2nd trimester. Chemotherapy is safe in 2nd trimester and should be started as it would be in a non-pregnant patient. Prompt diagnosis, timely intervention, multidisciplinary approach and successful integration of neoadjuvant chemotherapy are essential for a better outcome in these cases.